Cumberland Pharmaceuticals Inc.

Historical 13F Holders

Symbol
CPIX
CUSIP
230770109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 230770109 since 12/18/2024, largest first.

Filer % of Class Filed
A.J. Kazimi 13G 38.4% 2/9/2026
Event 1/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Ikarian Capital, LLC 13G
4.9% 5/15/2025
Event 3/31/2025
Integrated Core Strategies (US) LLC 13G/A
4.0% 10/30/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 15 1.72 M $13.5M
2026 Q2 33 2.47 M $16.0M
2026 Q1 30 2.76 M $8.97M
2025 Q4 28 2.96 M $11.8M
2025 Q3 31 3.41 M $10.6M
2025 Q2 33 3.68 M $12.3M
2025 Q1 36 4.28 M $18.1M
2024 Q4 22 1.84 M $4.36M
2024 Q3 24 2.04 M $2.61M
2024 Q2 24 2.08 M $3.18M
2024 Q1 24 2.16 M $3.63M
2023 Q4 26 2.20 M $3.89M
2023 Q3 22 2.21 M $4.17M
2023 Q2 24 2.40 M $3.52M
2023 Q1 22 2.45 M $4.77M
2022 Q4 24 2.49 M $5.61M
2022 Q3 18 2.45 M $5.89M
2022 Q2 25 2.71 M $5.62M
2022 Q1 29 2.90 M $8.17M
2021 Q4 28 2.84 M $13.2M
2021 Q3 24 2.77 M $7.43M
2021 Q2 29 2.94 M $8.36M
2021 Q1 32 3.23 M $9.77M
2020 Q4 29 3.88 M $11.4M
2020 Q3 28 4.03 M $12.9M
2020 Q2 31 4.14 M $13.8M
2020 Q1 27 4.67 M $17.0M
2019 Q4 28 4.46 M $23.0M
2019 Q3 29 4.48 M $26.6M
2019 Q2 25 4.77 M $30.4M
2019 Q1 24 4.93 M $28.6M
2018 Q4 28 4.99 M $30.5M
2018 Q3 34 5.38 M $30.7M
2018 Q2 30 5.39 M $33.0M
2018 Q1 29 5.43 M $36.2M
2017 Q4 31 5.43 M $40.1M
2017 Q3 33 5.42 M $38.3M
2017 Q2 34 5.45 M $38.3M
2017 Q1 36 5.51 M $38.2M
2016 Q4 41 5.48 M $30.2M
2016 Q3 41 5.42 M $27.1M
2016 Q2 44 5.24 M $23.6M
2016 Q1 48 5.22 M $23.4M
2015 Q4 47 5.13 M $27.0M
2015 Q3 48 5.21 M $30.1M
2015 Q2 46 5.20 M $37.2M
2015 Q1 46 5.47 M $36.4M
2014 Q4 45 5.72 M $34.2M
2014 Q3 45 6.36 M $31.4M
2014 Q2 45 6.67 M $30.0M
2014 Q1 47 6.72 M $30.2M